• Colon cancer patients taking GLP-1 drugs, like Ozempic, had better odds of survival in a new study. • Weight loss and diabetes injections have well-known anti-inflammatory benefits. • It could be that Ozempic starves tumors, turning off key pro-cancer proteins.

First, they were diabetes drugs. Then, weight loss blockbusters.

Now, scientists believe they have identified another potential benefit of injectable GLP-1 drugs like Ozempic and Mounjaro: fewer colon cancer deaths.

In a recent study, researchers at the University of California discovered that colon cancer patients who happened to be taking a GLP-1 drug like Ozempic or Mounjaro cut their risk of death in half over a five-year period.

Professor Raphael Cuomo, lead author of the new research, said his team tried to find othe

See Full Page